Pre Conference Workshop Day | Monday, November 18

Our pre-conference workshop day features sessions dedicated to hands-on learning activities, discussions, and networking opportunities. These workshops are interactive and educational, allowing participants to develop practical skills, gain knowledge, and engage in problem-solving exercises.

Workshop A: 9am – 12pm

Logistics of Donor Selection for Allogeneic Therapies to Optimize The Donor Selection Processes, Ensure High-Quality Therapeutic Impact & Increase Supply Chain Efficiency

Synopsis

This workshop is designed to provide a comprehensive understanding of the logistics of donor selection for allogeneic therapies. By the end of the workshop, participants will be equipped with a deep understanding of the principles of donor selection, practical solutions to logistical challenges, best practices for coordination, and effective

communication strategies. These skills will enhance the efficiency and success of allogeneic therapies within organizations, ultimately improving patient outcomes.

Join this workshop to:

  • Understand the fundamental principles of donor selection for allogeneic therapies to set up a logistics strategy
  • Identify how individuals are dealing with key logistical challenges such as viral testing, sample collection, donor retention, consistency of protocols (and more) and learn how to overcome them via collaboration with collection centers during the donor selection process
  • Learn best practices for coordinating between clinical teams, donors, and logistics providers
  • Implement effective communication strategies to ensure seamless donor management

Workshop B: 1pm- 4pm

Navigating Regulatory Challenges in Donor Selection for Allogeneic Therapies

  • Ivone Bruno Vice President - Preclinical Affairs, CytoImmune Therapeutics

Synopsis

Participants will gain an in-depth understanding of the primary regulatory challenges encountered in the donor selection process including harmonizing standards and ensuring compliance with stringent regulatory standards in the United States, Europe, and Asia. Participants will engage in practical discussions to develop compliant documentation and learn how to prepare for regulatory audits and inspections. By the end of the workshop, participants will be equipped with practical strategies to navigate the regulatory landscape of donor selection for allogeneic therapies.

Join this workshop to:

  • Understand the key regulatory challenges in the donor selection process for allogeneic therapies
  • Learn best practices for ensuring compliance standards on starting materials across US, Europe and Asia
  • Define standards across donor screening, testing, and quality assurance
  • Develop strategies for effective documentation and record-keeping
  • Implement ethical considerations and donor safety measures